This page includes the latest FDA filings for Acufocus Inc 32 Discoverysuite 200irvine Ca 92618 Pma Numberp210005 Supplement Numbers002 Date Received08 23 2022 Decision Date09 20 2022 Product Code Poe Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| AcuFocus, Inc.32 Discoverysuite 200irvine, CA 92618 PMA NumberP210005 Supplement NumberS002 Date Received08/23/2022 Decision Date09/20/2022 Product Code POE Advisory Committee Ophthalmic Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No | IC-8 Apthera Intraocular Lens (IOL) | 2022-09-20 |